Besides, recent studies found that dietary and herbal compounds, such as apigenin [34] and a synthetic derivative of curcumin called CDF (a novel curcumin-derived synthetic analogue) [77], could simultaneously inhibit HIF-1α and EZH2, reducing cancer invasiveness and improving tumor prognosis. Here, EZH2 is linked to cancer.